Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating the efficacy and safety of epinastine hydrochloride eye drops for seasonal allergic conjunctivitis in Chinese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Conjunctivitis

Drugs mentioned

• epinastine hydrochloride eye drops (epinastine hydrochloride)

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Seasonal Allergic Conjunctivitis | Phase 3 | Status: COMPLETED